AstroNova, Inc.
AstroNova, Inc. (ALOT) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for AstroNova, Inc. (ALOT), covering cash flow, earnings, and balance sheets.
AstroNova, Inc. (ALOT) Income Statement & Financial Overview
Explore comprehensive income reports for AstroNova, Inc. ALOT, broken down by year and quarter.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $37.36M | $40.42M | $40.54M | $32.96M |
| Cost of Revenue | $24.63M | $26.71M | $26.21M | $20.99M |
| Gross Profit | $12.74M | $13.71M | $14.33M | $11.97M |
| Gross Profit Ratio | $0.34 | $0.34 | $0.35 | $0.36 |
| R&D Expenses | $1.75M | $1.84M | $1.41M | $1.60M |
| SG&A Expenses | $9.89M | $10.61M | $11.85M | $9.02M |
| Operating Expenses | $25.05M | $12.45M | $13.27M | $10.63M |
| Total Costs & Expenses | $49.67M | $39.16M | $39.48M | $31.61M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $847000.00 | $944000.00 | $938000.00 | $482000.00 |
| Depreciation & Amortization | $1.27M | $1.30M | $1.30M | $911000.00 |
| EBITDA | -$11.14M | $2.56M | $2.19M | $2.26M |
| EBITDA Ratio | -$0.30 | $0.06 | $0.05 | $0.07 |
| Operating Income | -$12.31M | $1.26M | $1.06M | $1.35M |
| Operating Income Ratio | -$0.33 | $0.03 | $0.03 | $0.04 |
| Other Income/Expenses (Net) | -$947000.00 | -$990000.00 | -$1.11M | -$599000.00 |
| Income Before Tax | -$13.26M | $274000.00 | -$50000.00 | $747000.00 |
| Income Before Tax Ratio | -$0.35 | $0.007 | -$0.001 | $0.02 |
| Income Tax Expense | $2.34M | $34000.00 | $261000.00 | -$434000.00 |
| Net Income | -$15.60M | $240000.00 | -$311000.00 | $1.18M |
| Net Income Ratio | -$0.42 | $0.006 | -$0.008 | $0.04 |
| EPS | -$2.07 | $0.03 | -$0.04 | $0.16 |
| Diluted EPS | -$2.07 | $0.03 | -$0.04 | $0.15 |
| Weighted Avg Shares Outstanding | $7.53M | $7.52M | $7.52M | $7.46M |
| Weighted Avg Shares Outstanding (Diluted) | $7.53M | $7.61M | $7.52M | $7.63M |
Over the past four quarters, AstroNova, Inc. demonstrated steady revenue growth, increasing from $32.96M in Q1 2025 to $37.36M in Q4 2025. Operating income reached -$12.31M in Q4 2025, maintaining a consistent -33% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$11.14M, reflecting operational efficiency. Net income dropped to -$15.60M, with EPS at -$2.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan